These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4974058

  • 1. [Possible side-effects of antidotal therapy].
    Wirth W.
    Arch Toxikol; 1968; 24(1):71-82. PubMed ID: 4974058
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. B. Chelating agents].
    van Oye R.
    Bull Soc Belge Ophtalmol; 1972; 160(1):255-7. PubMed ID: 4625832
    [No Abstract] [Full Text] [Related]

  • 5. [Recent advance in the therapy of metal poisoning with complexing agents].
    Aaseth J.
    Tidsskr Nor Laegeforen; 1972 May 10; 12(13):918-22. PubMed ID: 4624035
    [No Abstract] [Full Text] [Related]

  • 6. [Antidotal therapy in alkylphosphate poisoning].
    Erdmann WD.
    Arch Toxikol; 1968 May 10; 24(1):30-40. PubMed ID: 5706088
    [No Abstract] [Full Text] [Related]

  • 7. [Antidotes in cyanide poisoning].
    Friedberg KD.
    Arch Toxikol; 1968 May 10; 24(1):41-8. PubMed ID: 5706089
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Commentary. New developments in metal antidotal properties of chelating agents.
    Catsch A, Harmuth-Hoene AE.
    Biochem Pharmacol; 1975 Sep 01; 24(17):1557-62. PubMed ID: 811227
    [No Abstract] [Full Text] [Related]

  • 10. Hydroxocobalamin as a cyanide antidote.
    DesLauriers CA, Burda AM, Wahl M.
    Am J Ther; 2006 Sep 01; 13(2):161-5. PubMed ID: 16645433
    [No Abstract] [Full Text] [Related]

  • 11. [Heavy metal antidotes].
    Klimmer OR.
    Arch Toxikol; 1968 Sep 01; 24(1):15-29. PubMed ID: 4974056
    [No Abstract] [Full Text] [Related]

  • 12. Antidotal therapy: pharmacokinetic aspects.
    Vale JA, Meredith TJ.
    Dev Toxicol Environ Sci; 1986 Sep 01; 12():329-38. PubMed ID: 3549234
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic chelating agents.
    Jones MM, Pratt TH.
    J Chem Educ; 1976 Jun 01; 53(6):342-7. PubMed ID: 818097
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The efficacy and adverse effects of dicobalt edetate in cyanide poisoning.
    Marrs TC, Thompson JP.
    Clin Toxicol (Phila); 2016 Sep 01; 54(8):609-14. PubMed ID: 27352227
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two men with lead poisoning.
    St George IM.
    N Z Med J; 1970 May 01; 71(456):294-7. PubMed ID: 4988850
    [No Abstract] [Full Text] [Related]

  • 19. Clinical applications of commonly used contemporary antidotes. A US perspective.
    Bowden CA, Krenzelok EP.
    Drug Saf; 1997 Jan 01; 16(1):9-47. PubMed ID: 9010641
    [Abstract] [Full Text] [Related]

  • 20. Hydroxocobalamin versus thiosulfate for cyanide poisoning.
    Kerns W, Beuhler M, Tomaszewski C.
    Ann Emerg Med; 2008 Mar 01; 51(3):338-9. PubMed ID: 18282534
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.